Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Probio-Tec
- Development stage
- Unknown
- Lead developer
- Chr. Hansen
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Probio-Tec is a brand name for a range of probiotic solutions and products developed and manufactured by the global bioscience company Chr. Hansen (now part of Novonesis). It is not a single drug but a trademark under which various combinations of clinically documented probiotic strains are marketed. [5, 10] Different Probio-Tec formulations exist, containing different strains targeted for various health benefits. For example, some formulations combine Lactobacillus rhamnosus (LGG) and Bifidobacterium animalis subsp. lactis (BB-12), which are two of the world's most studied probiotic strains. [1, 2, 6] Other formulations may include Lactobacillus acidophilus LA-5, Lactobacillus paracasei (F-19), or strains like GR-1 and RC-14 for vaginal health. [3, 8] These probiotics function by helping to maintain or restore the balance of the gut and vaginal microflora. [3, 8] Probio-Tec products have been investigated in clinical trials for various indications, including the prevention of irinotecan-induced diarrhea, management of obesity and related low-grade inflammation, and symptoms of irritable bowel syndrome (IBS). [9, 12, 17]
- Brand names
- Probio-Tec
Beyond the preview
Go deeper on Probio-Tec.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Probio-Tec.